Aldatu Biosciences
Aldatu Biosciences is a biotechnology company dedicated to developing molecular diagnostic assays based on real-time PCR technology. Their mission is to advance infectious disease diagnostics that facilitate society’s response to global health emergencies. They have established the PANDAA platform, a proprietary technology enabling target detection in highly variable genomic regions, which allows for fast, reliable, and cost-effective diagnostic tests for infectious diseases. The company focuses on diseases such as HIV, Lassa fever, Crimean-Congo Hemorrhagic Fever, Ebola, Marburg, Yellow Fever, and SARS-CoV-2, among others. They aim to improve patient healthcare access and outcomes through high-throughput, low-cost diagnostics. Aldatu Biosciences is committed to serving global health needs as a public benefit corporation.
Industries
Nr. of Employees
small (1-50)
Aldatu Biosciences
313 Pleasant Street, 1st Floor West, Watertown, MA 02472
Products
Pan-lineage filovirus detection kit (adaptive PCR)
Diagnostic kit designed for universal detection/differentiation of filoviruses using an adaptive PCR approach to account for sequence diversity across lineages.
Focused HIV drug-resistance genotyping kit (adaptive PCR)
Modular genotyping kit for detection of a selected panel of HIV drug resistance mutations across integrase, protease and reverse transcriptase regions using adaptive PCR and PreAmp workflows; kit sizing supports multiple patient samples per run.
SARS-CoV-2 detection and variant genotyping kits (adaptive PCR)
RT-qPCR kits for detection of SARS-CoV-2 and for variant genotyping that are designed to remain effective despite emerging viral mutations using adaptive PCR methods.
Pan-lineage Lassa and CCHF detection kits (adaptive PCR)
Diagnostic kits for universal detection of Lassa virus and Crimean-Congo hemorrhagic fever virus using adaptive PCR approaches to account for lineage diversity.
Hot-start reverse transcriptase formulation
Enzyme reagent optimized for RT-PCR workflows that supports hot-start performance.
Pan-lineage filovirus detection kit (adaptive PCR)
Diagnostic kit designed for universal detection/differentiation of filoviruses using an adaptive PCR approach to account for sequence diversity across lineages.
Focused HIV drug-resistance genotyping kit (adaptive PCR)
Modular genotyping kit for detection of a selected panel of HIV drug resistance mutations across integrase, protease and reverse transcriptase regions using adaptive PCR and PreAmp workflows; kit sizing supports multiple patient samples per run.
SARS-CoV-2 detection and variant genotyping kits (adaptive PCR)
RT-qPCR kits for detection of SARS-CoV-2 and for variant genotyping that are designed to remain effective despite emerging viral mutations using adaptive PCR methods.
Pan-lineage Lassa and CCHF detection kits (adaptive PCR)
Diagnostic kits for universal detection of Lassa virus and Crimean-Congo hemorrhagic fever virus using adaptive PCR approaches to account for lineage diversity.
Hot-start reverse transcriptase formulation
Enzyme reagent optimized for RT-PCR workflows that supports hot-start performance.
Services
High-complexity molecular testing services with sample pickup and rapid turnaround times for hospitals, employers, and institutions; testing uses adaptive PCR-based assays designed for variant robustness.
Distribution of evaluation and training kits, virtual or in-person training, and support for collaborative validation studies integrating kit use into existing laboratory workflows.
High-complexity molecular testing services with sample pickup and rapid turnaround times for hospitals, employers, and institutions; testing uses adaptive PCR-based assays designed for variant robustness.
Distribution of evaluation and training kits, virtual or in-person training, and support for collaborative validation studies integrating kit use into existing laboratory workflows.
Expertise Areas
- Molecular diagnostics (RT-qPCR)
- Focused genotyping for drug resistance
- Infectious disease and outbreak diagnostics
- Assay development and analytical validation
Key Technologies
- Adaptive PCR for sequence-diverse targets
- Real-time quantitative RT-PCR (RT-qPCR)
- Targeted genotyping of drug-resistance mutations
- RT-PCR Pre-amplification (PreAmp) for low-copy RNA
News & Updates
Aldatu Biosciences received a grant to develop pan-filovirus testing for the outbreak in Tanzania.
The company received a grant to develop detection for Crimean-Congo Hemorrhagic Fever Virus.
Expanded lab and R&D space to provide rapid COVID-19 testing with results within 24 hours.
Awarded a $3 million SBIR grant from NIH to develop universal detection of CCHFV.
Aldatu Biosciences received a grant to develop pan-filovirus testing for the outbreak in Tanzania.
The company received a grant to develop detection for Crimean-Congo Hemorrhagic Fever Virus.
Expanded lab and R&D space to provide rapid COVID-19 testing with results within 24 hours.
Awarded a $3 million SBIR grant from NIH to develop universal detection of CCHFV.